Abstract

The use of botanical products in the United States and European countries is extensive. While the original intention of the Dietary Supplements and Health Education Act of 1994 (DSHEA) by the US Congress was to use these products for the purpose of “supplementing” the diet, however many consumers use them for managing their disease states. Among the dietary supplements that have been popular among individuals who suffer from anxiety or insomnia is kava (Piper methysticum Frost F.) (The word “methysticum” is Greek for intoxicant, and “Piper” is for pepper. Taken together, kava is an “intoxicating pepper”) [1]. The herb is native to South Pacific region (Melanesia, Micronesia, Polynesia, and Hawaii) where it has been in use for centuries as a traditional beverage. The natives prepare kava drink by masticating the rhizomes which are further diluted with either coconut milk or water [2]. South Pacific islanders use the drink to connect to their gods and ancestors through religious and ceremonial gatherings, to alleviate fatigue, and as a relaxant [3]. The word kava when used by the natives refers to both the shrub itself and the psychoactive drink that is made from its rhizomes [2]. Kava beverage has a bitter and acrid taste which is known by the natives as ‘awa’ [2].

Highlights

  • The use of botanical products in the United States and European countries is extensive

  • While the original intention of the Dietary Supplements and Health Education Act of 1994 (DSHEA) by the US Congress was to use these products for the purpose of “supplementing” the diet, many consumers use them for managing their disease states

  • The herb is native to South Pacific region (Melanesia, Micronesia, Polynesia, and Hawaii) where it has been in use for centuries as a traditional beverage

Read more

Summary

Introduction

The use of botanical products in the United States and European countries is extensive. The natives prepare kava drink by masticating the rhizomes which are further diluted with either coconut milk or water [2]. In 2002, kava’s import and use in Europe was greatly hindered by the health authorities citing toxicity concerns.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.